TROMSØ, NORWAY: ArcticZymes Technologies (OSE:AZT) announced the nomination of Dr. Frank Mathias as the new Chairman of the Board. Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the cell and gene therapy industry. Dr. Mathias was previously the CEO of Rentschler Biopharma SE, which he successfully developed into a leading…